We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Quadrise Fuels International Plc | LSE:QFI | London | Ordinary Share | GB00B11DDB67 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.5175 | 1.49 | 1.545 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
26/6/2022 19:34 | "a number of options being investigated" zzzzzzzzz - broken record "The Quadrise trial equipment is in Morocco, and production of the fuel will commence upon signature of the updated agreement" Translation : a screwdriver arrived in the post ? - but the updated agreement has still not been agreed "The selection of suitable MSC LONO vessels and fuel production sites are also in progress" Translation : still haven't found a suitable vessel "Commercial supply of bioMSAR(TM) to MSC would then be expected to commence in early Q4 2023, following receipt of a LONO from Wärtsilä." Extremely unlikely imo | kreature | |
26/6/2022 19:25 | "Following positive engagement"........I think I prefer " close discussions" still hats off to QFI for trying to mix it up a bit | kop202 | |
26/6/2022 16:41 | Company") Operational Update Quadrise (AIM:QFI) , the supplier of MSAR(R) and bioMSAR(TM) emulsion technology and fuels, providing innovative lower cost and lower carbon alternatives to fuel oil and biofuels , presents an update following a board review of the Company's projects, operations and business development activities. Summary -- The conclusion of the board review is that the Company is on track to achieve its commercialisation targets following positive engagement with counterparties during the past month. The Company therefore intends to progress with each of its core projects as well as with the development of bioMSAR(TM) fuel and its derivatives. -- MSC - Quadrise recently met with MSC executive management in Cyprus and both parties are now working to finalise an agreement covering the LONO trial programme aboard MSC container shipping vessels and the subsequent commercial framework. The conclusion of the board review is that the Company is on track to achieve its commercialisation targets following positive engagement with counterparties during the past month. The Company therefore intends to progress with each of its core projects as well as with the development of bioMSAR(TM) fuel and its derivatives. -- Morocco - an updated Material Transfer and Cooperation Agreement with our international chemicals and mining client is now expected to be signed this month ahead of an MSAR (R) combustion trial that is expected to conclude early Q3 2022. -- Utah - following signing of Commercial Development Agreement ("CDA") in April 2022, Quadrise and Valkor have commenced preparatory steps under Phase 1 of the CDA to identify target consumers of MSAR (R) and bioMSAR (TM) fuel. -- Testing with Aquafuel this quarter will conclude the bioMSAR(TM) engine efficiency optimisation work, with results expected in early Q3 2022. -- D iscussions are underway with several candidate sites in Panama and Honduras for MSAR (R) and bioMSAR (TM) power plant trials later in 2022. MSC Quadrise and MSC Shipmanagement continue to progress finalisation of an agreement covering the LONO trial programme aboard MSC container shipping vessels and the subsequent commercial framework, following a positive meeting recently with MSC executive management in Cyprus. In parallel, preparations for the 4,000-hour LONO trial continue, with the procurement process for the vessel fuel booster system now underway. The selection of suitable MSC LONO vessels and fuel production sites are also in progress, with a number of options being investigated to minimise cost, time and risk. The testing of MSAR(R) and bioMSAR(TM) on Wärtsilä's optical combustion chamber is now scheduled for Q3 2022, followed by injector wear rig testing on bioMSAR(TM) in Q4 2022, due to unavailability of key resources at Wärtsilä and their testing partners. Quadrise and Wärtsilä are working together to ensure there are no further delays to this programme during 2022. Assuming timely conclusion of this framework agreement, and associated agreements with other project stakeholders during 2022, the trials themselves are expected to commence before the end of this calendar year, and will take approximately 9 months to conclude. Commercial supply of bioMSAR(TM) to MSC would then be expected to commence in early Q4 2023, following receipt of a LONO from Wärtsilä. Morocco Quadrise continues to work with the client team to finalise terms on an updated Material Transfer and Cooperation Agreement with our international chemicals and mining client following the expiry of the prior agreement in December 2021. It is currently expected that this updated agreement will be entered into prior to the end of May 2022. As previously announced by the Company, the first of the Moroccan site trials will be at "Site B", which accounts for around one third of the client's annual HFO consumption, where 60mt of MSAR(R) will be combusted on one of the client's industrial units. A smaller trial of bioMSAR(TM) will also take place on the same unit after the MSAR(R) test. The Quadrise trial equipment is in Morocco, and production of the fuel will commence upon signature of the updated agreement. The Site B trial is expected to conclude in Q3 2022. Assuming the successful conclusion of the Site B trial, the intention is then to negotiate and conclude a commercial supply agreement covering one or more of the client's sites in Morocco. A feasibility study for use of MSAR(R) at a second client site ("Site A") is close to completion. This may lead to a further trial agreement, and if successful enhance the value and volume of the commercial supply agreement for MSAR(R). Utah As announced on 11 April 2022, Quadrise entered into a Commercial Development Agreement ("CDA") with Valkor Technologies LLC ("Valkor") to commercialise Quadrise's MSAR(R) and bioMSAR(TM) technologies at their projects in Utah. Quadrise awaits the delivery of a crude oil assay from a Valkor heavy oil asset (the 'Primary Project') in Utah. Following delivery, Quadrise will perform the envisaged analysis and, if required, will test a field sample to confirm that it is suitable as feedstock for the production of MSAR(R) and bioMSAR(TM). In addition, Quadrise and Valkor have begun working together under Phase 1 of the CDA to identify target consumers of MSAR (R) and bioMSAR (TM) fuel to be produced by the Utah heavy oil asset in which Valkor has an equity interest (the " Primary Project"), following which supply agreements will be negotiated with these identified target consumers. Under the terms of the CDA, both of these Phase 1 activities are to be completed prior to 30 June 2022, after which commercial terms for an MSAR (R) and/or bioMSAR (TM) License and Supply Agreement at the Primary Project would be concluded no later than October 2022. Latin America Quadrise and its local agents, E&PC, are progressing discussions with several candidate sites in Panama and Honduras to trial MSAR(R) and bioMSAR(TM) later in 2022 at a power plant equipped with Wärtsilä diesel engines, as a precursor to potential commercial supply in 2023. In Mexico, the Company submitted a multi-site study to the National Oil Company supporting the implementation of MSAR(R) technology. Documentation is being prepared for one of the sites identified that could lead to a demonstration of MSAR(R) refinery refueling on a fuel oil consuming unit later in 2022. bioMSAR(TM) & Transition Solutions Following the positive results of bioMSAR(TM) testing on a Wärtsilä diesel engine at the VTT facility in Finland and on a high-speed 4-stroke Cummins diesel engine at Aquafuel, a final round of testing has been scheduled at Aquafuel to commence later in Q2. This will conclude the bioMSAR(TM) engine efficiency optimisation work, with results expected early in Q3 2022. During the period, Quadrise conducted a detailed analysis of the crude glycerine market and appointed a consultant to review global sourcing and partnerships for supply and refining. Commercial and supply discussions are underway with various biodiesel suppliers to secure the required volumes and quality of renewable, fuel-grade glycerine to support the forthcoming MSC trials and as a source for future bioMSAR(TM) commercialisation. In addition, Quadrise continue to investigate alternative methods of sourcing renewable glycerine from non-conventional sources, including algal production. An international patent application for bioMSAR(TM) and a UK patent for our novel blending technology has been submitted jointly with Nouryon and complements our existing MSAR(R) IP. Our RDI team continue to test low-carbon future fuels, as part of our energy transition activities to offer a Net Zero solution | hazl | |
26/6/2022 16:39 | Ha ha you boys don't like it finishing blue do you? | hazl | |
26/6/2022 16:34 | On track lol What for, a placing ? | kreature | |
26/6/2022 13:32 | HazlYou'll have to excuse my overt cynicism...but I have to chuckle when I see your comment "on track".....God I hope your right and your optimism is warranted | kop202 | |
26/6/2022 13:25 | Hey they mean business! | hazl | |
26/6/2022 13:21 | The oceans are our heritage and they are our future. At @MSCcargo we are taking active steps to protect our oceans while also conducting global shipping in a safe and reliable way. You can read more here | hazl | |
26/6/2022 13:17 | 'The conclusion of the board review is that the Company is on track to achieve its commercialisation targets following positive engagement with counterparties during the past month. The Company therefore intends to progress with each of its core projects as well as with the development of bioMSAR(TM) fuel and its derivatives. -- MSC - Quadrise recently met with MSC executive management in Cyprus and both parties are now working to finalise an agreement covering the LONO trial programme aboard MSC container shipping vessels and the subsequent commercial framework. The conclusion of the board review is that the Company is on track to achieve its commercialisation targets following positive engagement with counterparties during the past month. The Company therefore intends to progress with each of its core projects as well as with the development of bioMSAR(TM) fuel and its derivatives. -- Morocco - an updated Material Transfer and Cooperation Agreement with our international chemicals and mining client is now expected to be signed this month ahead of an MSAR (R) combustion trial that is expected to conclude early Q3 2022. Note....the Morocco deal cited here has happened this month. | hazl | |
26/6/2022 10:27 | Hazl...roll-on next week?....Why? What's happening?.......Is it your birthday?, | kop202 | |
26/6/2022 10:20 | Hazl..and the week after that...and the month after that ...and the year after that.....your shaping up to be the ideal QFI investor....you'll soon be taking Miles and his perennial announcenents of "close discussions" uneventful MOU's in your stride ....Miles must have earned over £2million to date....Mike Kirk 300 grand a year...both to show...AIM investors deserve better... | kop202 | |
26/6/2022 09:41 | So you're saying it's better to buy at a high when everyone's interested and it turns out to be a tipping point? I see. The success comes when you buy at a low and few people are interested . Of course there must be some signatures and good news first, which I still believe in, but who knows? DYOR. | hazl | |
25/6/2022 22:54 | Sorry I don't mean to spoil your fun. Carry on. ATB | kreature | |
25/6/2022 22:53 | but your talking a handful of trades, possibly from less that a handful of players. It's not like the average US household owns QFI shares | kreature | |
25/6/2022 16:45 | Roll on next week! | hazl | |
25/6/2022 16:45 | Not at al l. Risks are less tolerated in a dropping market. We have held up well compared to many. We closed blue! | hazl | |
25/6/2022 09:18 | No correlation tho. Shouldn’t you write ‘off topic’ before that? | kreature | |
25/6/2022 08:04 | We might not be out of the woods yet but short term welcome news. | hazl | |
25/6/2022 08:02 | Looks better over in the US. Hopefully be reflected positively over here next week. By Bill McColl, Newsletter Contributor 'U.S. equity markets are soaring as St. Louis Federal Reserve Bank President James Bullard said fears about recession are overblown, and a survey of consumers shows their long-term outlook for inflation has eased. The Dow, S&P 500, and Nasdaq are all higher by more than 2%, and are on pace for a weekly gain. ' Thanks to investopedia....a site I like. | hazl | |
24/6/2022 18:24 | This will only move on news... we know this. So why don't you people go to shares that interest you more. | hazl | |
24/6/2022 18:22 | Wow you guru! Show me one that is absolutely safe in this market! Now copy and paste that over to PURP.... that's obviously al l you're good at. Incompetence personnified. | hazl | |
24/6/2022 17:21 | I have to agree... "speculative", "dangerous", "great risk", "don't put too much into these shares" | kreature | |
24/6/2022 17:19 | I'm afraid you are yet to impress me. | hazl | |
24/6/2022 17:07 | You must check out a few on the web. They've invested £100 in thousands of air coins. One of them should work. | tongosti |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions